NCT03738904View on ClinicalTrials.gov

Prospective Randomized Controlled Trial of an Enhanced Recovery Protocol for Anorectal Surgery

PHASE4CompletedINTERVENTIONAL
Enrollment

111

Participants

Timeline

Start Date

October 26, 2018

Primary Completion Date

August 18, 2022

Study Completion Date

August 18, 2022

Conditions
Anorectal Disorder
Interventions
COMBINATION_PRODUCT

ERAS

Gabapentin Acetaminophen Ketoroloac IV (intraop) and PO Dexamethasone (included with benzocaine in local anesthesia) Oxycodone PO Polyethylene glycol

COMBINATION_PRODUCT

Standard of care

Oxcodone PO Ketorolac IV only (intraop)

Trial Locations (1)

90048

Cedars Sinai, Los Angeles

All Listed Sponsors
lead

Cedars-Sinai Medical Center

OTHER

NCT03738904 - Prospective Randomized Controlled Trial of an Enhanced Recovery Protocol for Anorectal Surgery | Biotech Hunter | Biotech Hunter